Sustained-release hydrophilic matrix tablets of zileuton Formulation and in vitro/in vivo studies
Qiu, Y.; Cheskin, H.; Briskin, J.; Engh, K.; Hui, H.W.; Semla, S.
Pharmaceutical Research (New York) 13(9 Suppl): S291
1996
ISSN/ISBN: 0724-8741
DOI: 10.1016/s0168-3659(96)01574-x
Accession: 033606664
PDF emailed within 0-6 h: $19.90
Related References
Qiu, Y.; Cheskin, H.; Briskin, J.; Engh, K. 1997: Sustained-released hydrophilic matrix tablets of zileuton: Formulation and in vitro/in vivo studies Journal of Controlled Release 45(3): 249-256Qiu, Y.; Hui, H.W.; Cheskin, H. 1997: Formulation development of sustained-release hydrophilic matrix tablets of zileuton Pharmaceutical Development and Technology 2(3): 197-204
Emami, J.; Tavakoli, N.; Movahedian, A. 2004: Formulation of sustained - release lithium carbonate matrix tablets: influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation Journal of Pharmacy and Pharmaceutical Sciences: a Publication of the Canadian Society for Pharmaceutical Sciences Societe Canadienne des Sciences Pharmaceutiques 7(3): 338-344
Hui, H.W.; Awni, W.; Qiu, Y.; Semla, S.; Papp, K.; Cheskin, H. 1996: Controlled release of zileuton from monolith matrix tablets In-vitro studies and in-vivo evaluation in healthy volunteers Pharmaceutical Research (New York) 13(9 Suppl): S289
Varshosaz, J.; Tavakoli, N.; Kheirolahi, F. 2006: Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride Aaps Pharmscitech 7(1): E24
Varshosaz, J.; Tavakoli, N.; Kheirolahi, F. 2006: Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride Aaps Pharmscitech 7(1): E168-E174
Zhu, Y.; Yu, J.; Zhou, G.; Gu, Z.; Adu-Frimpong, M.; Deng, W.; Yu, J.; Xu, X. 2020: Piperine fast disintegrating tablets comprising sustained-release matrix pellets with enhanced bioavailability: formulation, in vitro and in vivo evaluation Pharmaceutical Development and Technology 25(5): 617-624
Chaibva, F.A.; Walker, R.B. 2012: The use of response surface methodology for the formulation and optimization of salbutamol sulfate hydrophilic matrix sustained release tablets Pharmaceutical Development and Technology 17(5): 594-606
Ichihashi, H. 2000: Formulation design of nifedipine sustained-release tablets CR tablet based on coat-core technology of hydrophilic-matrix Membrane 25(2): 60-66
Owayez, A.S.; Abd El-Ghany, G.M.; Abu Hashim, I.I. 2017: Potential use of Polyvinyl Acetate-Polyvinylpyrrolidone Mixture for the Development of Atenolol Sustained Release Matrix Tablets: Optimization of Formulation through in Vitro-in Vivo Assessment Study Chemical and Pharmaceutical Bulletin 65(6): 545-557
Abdelkader, H.; Abdalla, O.Y.; Salem, H. 2007: Formulation of controlled-release baclofen matrix tablets: influence of some hydrophilic polymers on the release rate and in vitro evaluation Aaps Pharmscitech 8(4): E100
Hamza, Y.E.-S.; Aburahma, M.H. 2010: Design and in vitro evaluation of novel sustained- release matrix tablets for lornoxicam based on the combination of hydrophilic matrix formers and basic pH-modifiers Pharmaceutical Development and Technology 15(2): 139-153
Xu, F.-F.; Shi, W.; Zhang, H.; Guo, Q.-M.; Wang Zhen-Zhong; Bi, Y.-A.; Wang, Z.-M.; Xiao, W. 2015: Preparation of hydrophilic matrix sustained release tablets of total lactones from Andrographis paniculata and study on its in vitro release mechanism Zhongguo Zhong Yao Za Zhi 40(1): 79-83
Hayashi, T.; Kanbe, H.; Okada, M.; Kawase, I.; Ikeda, Y.; Onuki, Y.; Kaneko, T.; Sonobe, T. 2007: In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets International Journal of Pharmaceutics 341(1-2): 105-113
Soutric J. 1986: Tablets of sustained release theophylline hydrophilic matrix type bioavailability studies Acta Farmaceutica Bonaerense 5(1): 15-20
Reddy, K.R.; Mutalik, S.; Reddy, S. 2003: Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation Aaps Pharmscitech 4(4): E61
Milanowski, B.ło.; Hejduk, A.; Bawiec, M.A.; Jakubowska, E.; Urbańska, A.; Wiśniewska, A.; Garbacz, G.; Lulek, J. 2020: Biorelevant in Vitro Release Testing and in Vivo Study of Extended-Release Niacin Hydrophilic Matrix Tablets Aaps Pharmscitech 21(3): 83
Jamil, Q.A.; Masood, M.I.; Jamil, M.N.; Masood, I.; Iqbal, S.M. 2017: Formulation and in vitro evaluation of sustained release matrix tablets using cross-linked natural gum Pakistan Journal of Pharmaceutical Sciences 30(2): 355-362
Singhvi, G.; Shah, A.; Yadav, N.; Saha, R.N. 2014: Study the effect of formulation variables on drug release from hydrophilic matrix tablets of milnacipran and prediction of in-vivo plasma profile Pharmaceutical Development and Technology 19(6): 708-716
Srivastava, A.K.; Singh, J.; Jayaswal, S.B. 1982: Formulation of sustained release chlorpheniramine maleate tablets in vitro study and in vitro in vivo correlation Indian Journal of Pharmaceutical Sciences 44(1): 24